ICON is an Ireland-based contract research firm that provides services such as drug development and clinical research for sectors including pharmaceutical and biotechnology.Read more
ICON's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 3.5B. Over the last four quarters, ICON's revenue has grown by 118.3%. Specifically, in Q1 2022's revenue was $1.9B; in Q4 2021, it was $1.9B; in Q3 2021, it was $1.9B; in Q2 2021, ICON's revenue was $871.2M.